How many institutions held SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value in Q2 2020?

77 institutional investors reported SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value for Q2 2020. Use the holders table for investor-level position and value details.

Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS)

Q: What does CUSIP 87184Q107 represent in this 13F holders report?

CUSIP 87184Q107 is the security identifier for SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 87184Q107

Q2 2020 13F Holders as of 30 Jun 2020

Security type / class: Equity / Common Stock, $0.001 par value
Total 13F shares: 39,975,459
Total 13F value: $425,248,905
Share change: +29,918
SEC-reported price per share: $10.66
Number of holders: 77
Value change: +$6,981,050
Number of buys: 56
Number of sells: 19
Shares outstanding: 27,995,500

Security key

87184Q107

Report period

Q2 2020

Institutions

Top holders

SYRS full security history Ownership snapshot Full 13F holder table Syros Pharmaceuticals, Inc. SEC filings Syros Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

FMR LLC

Disclosed value leader

FMR LLC

Comparable rows

15/15

Latest evidence

31 Mar 2020

13F Lead comparable stake: 22% Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 22%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.

Comparable ownership Top 5

FMR LLC 22%

ARK Investment Management LLC 21%

Amova Asset Management Americas, ... 18%

Sumitomo Mitsui Trust Group, Inc. 18%

ARCH Venture Management, LLC 11%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
FMR LLC	13F Company 13F	22%	$37,234,000 6,278,984 shares	—	31 Mar 2020
ARK Investment Management LLC	13F Company 13F	21%	$34,983,000 5,899,398 shares	—	31 Mar 2020
Amova Asset Management Americas, Inc.	13F Company 13F	18%	$29,206,000 4,925,206 shares	—	31 Mar 2020
Sumitomo Mitsui Trust Group, Inc.	13F Company 13F	18%	$29,206,000 4,925,206 shares	—	31 Mar 2020
ARCH Venture Management, LLC	13F Company 13F	11%	$18,168,000 3,063,817 shares	—	31 Mar 2020
Flagship Pioneering, LLC	13F Company 13F	10%	$17,425,000 2,938,494 shares	—	31 Mar 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

39,975,459

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

Q2 2020 holders

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 value	Q2 2020 value	Value change	Value Chg %